N
Nuvectis Pharma D
D
NVCT
8.16000
USD
0.70
(9.38%)
Market Closed
Volume
4,358
EPS
0
Div Yield
0
P/E
-6
Market Cap
152,205,934
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Nuvectis Pharma
Sector: Healthcare
Industry: Biotechnology
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.